Home688266 • SHA
add
Suzhou Zelgen Biopharmaceuticals Co Ltd
Previous close
¥86.61
Day range
¥87.00 - ¥92.85
Year range
¥43.82 - ¥92.85
Market cap
17.42B CNY
Avg Volume
2.18M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 149.79M | 43.57% |
Operating expense | 189.62M | -26.11% |
Net income | -38.31M | 49.91% |
Net profit margin | -25.58 | 65.11% |
Earnings per share | — | — |
EBITDA | -2.18M | 98.56% |
Effective tax rate | 34.93% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | 274.55M | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -1.44% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -38.31M | 49.91% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Mar 18, 2009
Website
Employees
858